NewHydrogen, Inc.

EFFECT effective

The current filing is a Notice of Effectiveness for NewHydrogen, Inc.'s registration statement, confirming the SEC has accepted the filing to allow the company to proceed with its securities offering. The previous 424B4 filing detailed a prospectus for the sale of up to 235 million shares of common stock under an Equity Financing Agreement with GHS Investments, LLC, which remains the core structure of the offering.

424B4 priced

NewHydrogen, Inc. filed a 424B4 prospectus for the resale of up to 235,000,000 shares of common stock by a selling stockholder, facilitated by an Equity Financing Agreement with GHS Investments, LLC. The agreement allows the company to sell up to $3.0 million in shares over 24 months, with terms dependent on market conditions. The company focuses on thermochemical green hydrogen production but faces significant risks including historical losses, reliance on key personnel, and market uncertainties.

EFFECT effective

NewHydrogen, Inc. has received SEC approval for its initial public offering (IPO) registration, as indicated by the 'Notice of Effectiveness' dated May 30, 2025. The filing confirms the effectiveness of the S-1 registration statement, but no additional details about the company's business, financials, or offering terms are provided in the text.

S-1 filed

NewHydrogen, Inc. is a clean energy technology company focused on developing electrolyzer technology to reduce the cost of green hydrogen production. The current S-1 filing updates previous disclosures from the 424B3, which outlined an offering of 89,583,334 shares of common stock by selling stockholders, including shares from warrant exercises. The company emphasizes its mission to replace expensive catalysts in electrolyzers with earth-abundant materials, targeting a $12 trillion green hydrogen market by 2050. However, the filing highlights ongoing financial challenges, including a history of losses and reliance on external financing.

424B3 priced

89,583,334 shares · Gross proceeds $5,400,000

NewHydrogen, Inc. is offering up to 89,583,334 shares of common stock through selling stockholders, including shares from warrant exercises and placement agent warrants. The company will not receive proceeds from the sale but will collect $5.4 million upon warrant exercises. The stock is quoted on OTC Pink under 'NEWH'. The filing details the plan of distribution and risks associated with the offering.

EFFECT effective

NewHydrogen, Inc. (formerly BioSolar, Inc.) filed a Notice of Effectiveness for its securities offering on October 1, 2021. The offering, previously disclosed in a 424B5 filing, involves 65,000,000 shares of common stock and warrants to purchase up to 125,000,000 shares, with an exercise price of $0.04 per share. The company aims to use proceeds to advance electrolyzer technology for green hydrogen production and for general corporate purposes. The offering was registered under a shelf registration statement, allowing flexibility to sell securities up to $100 million.

424B5 priced

Price $0.04 · 65,000,000 shares · Gross proceeds $4,994,000

BioSolar, Inc. is offering 65,000,000 shares of common stock and warrants to purchase up to 125,000,000 shares, along with pre-funded warrants and placement agent warrants. The offering aims to raise approximately $4.6 million for electrolyzer technology development and general corporate purposes. The common stock is quoted on OTC Pink under BSRC, with no established trading market for warrants. The placement agent is H.C. Wainwright & Co., LLC.

EFFECT effective

The filing marks the effectiveness of BioSolar Inc's S-3 registration statement on March 25, 2021, following an earlier S-1 filing on February 5, 2021. The transition from S-1 to S-3 suggests the company may have completed initial registration requirements and is now utilizing a shelf registration for future securities offerings.

424B3 priced

Price $0.11 · 172,916,668 shares · Gross proceeds $0.00

The current 424B3 filing by BioSolar, Inc. (NewHydrogen) relates to the resale of up to 172,916,668 shares of common stock by selling stockholders, including shares from warrants, pre-funded warrants, and placement agent warrants issued in a January 2021 private placement. The company will not receive proceeds from the resale but will collect $5 million from warrant exercises. The shares are quoted on OTC Pink under BSRC, with a fixed offering price of $0.1134 per share until OTCQB listing. The filing emphasizes risks related to the company's unproven technology, limited operating history, and dependence on external financing.

EFFECT effective

The Notice of Effectiveness confirms the registration of BioSolar, Inc.'s S-1 filing, allowing the resale of 172,916,668 shares of common stock by selling stockholders. The offering includes shares from warrants, pre-funded warrants, and placement agent warrants issued in a January 2021 private placement. The company, focused on clean energy technologies like electrolyzer systems for green hydrogen production and lithium-ion battery innovations, does not receive proceeds from the stock sales but may receive $5.47 million from warrant exercises. The stock is quoted on the OTC Pink under BSRC.

S-1 filed

Price $0.11 · 172,916,668 shares

BioSolar, Inc. is offering 172,916,668 shares of common stock through selling stockholders, including shares from warrants, pre-funded warrants, and placement agent warrants. The company focuses on developing clean energy technologies, particularly electrolyzer systems for green hydrogen production and lithium-ion battery improvements. The offering follows a private placement and seeks OTCQB listing, with no direct proceeds to the company but potential warrant exercise proceeds of $5.46 million. The company has a history of losses and operates in a highly competitive, unproven market.

424B3 priced

Price $0.10 · 26,500,000 shares

BioSolar, Inc. is registering 26,500,000 shares of common stock for resale by selling stockholders. The company, a development-stage firm focused on thin-film solar cell technology, has no revenue, limited operating history, and significant risks including dependence on key personnel and unproven technology. The offering does not involve the company receiving proceeds, and shares are not traded on any exchange.

EFFECT effective

BioSolar Inc. (now NewHydrogen, Inc.) filed a Notice of Effectiveness for its SB-2 registration statement on February 14, 2007. The filing relates to the resale of 26.5 million shares of common stock by selling stockholders, with no proceeds going to the company. The prospectus highlights risks associated with the company's limited operating history, lack of revenue, and dependence on research and development. The company focuses on thin-film solar cell technology using bio-based substrates but has not yet achieved profitability.